In Market Access we are at home

We provide a complete range of services required by applicable legislation in the field of drug policy.

Our solutions

Better health. Our challenge.

We have many successful projects behind us that have led to the introduction of innovative treatment options and their availability for patients in Slovakia in various therapeutic areas.

We have helped

launch many innovative treatment options for Slovak patients


innovative drugs


drugs classed as “breakthrough therapy“


drugs with the designation “orphan” drug


diseases (in reference)

We cherish  data.

In the categorization process, when including drugs to the reimbursement system it is necessary to submit current data on therapeutic practices, expenditure and disease epidemiology in the Slovak Republic.